Myeloproliferative neoplasms (MPNs) are chronic disorders that cause excessive production of blood cells. These blood cells are formed in the bone marrow by hematopoietic “stem cells” that create all of the different blood cell types. These stem cells produce red blood cells, white blood cells, and platelets. Each of these blood components plays a different role, and in MPNs the ratio and number of the red blood cells, white blood cells and platelets is out of balance.
Learn more about MPNs, our research and treatments.
The classic chronic myeloproliferative neoplasms (MPNs) are polycythemia vera (PV), essential thrombocythemia (ET), chronic myeloid leukemia (CML), and primary myelofibrosis (MF). There are also many complications common to patients with MPNs. Learn more about these conditions and the best ways to treat them.
Due to breakthrough research into the causes of myeloproliferative neoplasms (MPNs), treatment possibilities continue to expand. Learn more about the latest MPN treatment options.
Answers to frequently asked questions (FAQs) about what causes MPNs, and how they are diagnosed and treated.
Clinical trials are vital to research, discovery, and patient care at Weill Cornell Medicine and NewYork-Presbyterian. Learn more about our open clinical trials for people with myeloproliferative neoplasms (MPNs).